NASDAQ · HCAT

Health Catalyst, Inc.

$2.15 +$0.07 (+3.37%) 1D Market open

Key Metrics

$153.70M
Market cap
P/E · TTM
−$8.66M
Revenue · TTM
−$87.28M
Net income
EPS · TTM $-1.27
Dividend yield
Free cash flow
Beta · 1Y 1.52
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 4
    The stock moved +45.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 4
  • Apr 10
    From its Feb 2 high, the share price fell 57%.

    Peak close $2.30 on Feb 2; trough close $1.00 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -57%
  • Mar 13
    The stock moved -26.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$153.70M
Enterprise value$198.24M
Shares outstanding73.9M
52-wk range$0.96 – $4.11
Avg volume · 20D665.2K
Net cash −$44.54M
Book value / share$2.02
IndustryServices-Computer Programming, Data Processing, Etc.
ExchangeNASDAQ
About Health Catalyst, Inc.
IPO dateJul 25, 2019
Employees1200

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating 997.0%
Net 1,008.2%
FCF
ROE / ROIC -63.2% · —

Financial Health

Current ratio1.69
Quick ratio
Debt / equity1.11
Debt / EBITDA
Net cash −$44.54M
Working capital$74.70M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-5.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings